After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
Stocks Info
Arcturus Therapeutics Holdings Inc is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. The current market capitalization of Arcturus Therapeutics Holdings Inc is $479.72M. A total of 0.61 million shares were traded on the day, compared to an average of 427.89K shares.
In the most recent transaction, Chivukula Pad sold 12,000 shares of ARCT for 20.76 per share on Oct 15 ’24. After the transaction, the Chief Scientific Officer & COO now owns 435,334 company shares. In a previous transaction on Oct 15 ’24, Chivukula Pad bought 12,000 shares at 20.76 per share.
Among the insiders who sold shares, SASSINE ANDY disposed of 50,000 shares on Jun 12 ’24 at a per-share price of $32.03. This resulted in the Chief Financial Officer holding 220,526 shares of ARCT after the transaction. In another insider transaction, Chivukula Pad sold 114 shares at $45.00 per share on Jun 05 ’24. Company shares held by the Chief Scientific Officer & COO now total 447,334.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, ARCT has a high of $45.00 and a low of $14.30.
As of this writing, ARCT has an earnings estimate of -$0.49 per share for the current quarter. EPS was calculated based on a consensus of 9.0 estimates, with a high estimate of $0.59 per share and a lower estimate of -$1.24.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. ARCT’s latest balance sheet shows that the firm has $370.49M in Cash & Short Term Investments as of fiscal 2021. There were $69.15M in debt and $99.54M in liabilities at the time. Its Book Value Per Share was $9.67, while its Total Shareholder’s Equity was $228.21M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ARCT is Buy with a score of 5.00.
